Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: An open pilot trial

Dermatologic Surgery

Volumn 30, Issue 10, 2004, Pages 1279-1286

  Jones, Derek H ^a,f   Carruthers, Alastair ^b   Orentreich, David ^c   Brody, Harold J ^d   Lai, Mei Ying ^e   Azen, Stanley ^e   Van Dyke, Gregory S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; SILICONE OIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FACE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED FACIAL LIPOATROPHY; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; SKIN INFECTION;

ADULT; DIMETHYLPOLYSILOXANES; FACE; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PILOT PROJECTS; SILICONE OILS; SILICONES; TREATMENT OUTCOME;

EID: 7044250709     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30406.x     Document Type: Article

References (13)

1. Lictenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001;15:1389-98.
2. Jones D. HIV facial lipoatrophy: etiology and methods of correction. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. New York: Dekker, 2003: in press.
3. Jones DH. Injectable silicone for facial lipoatrophy. Cosmet Dermatol 2002;15:13-5.
4. Orentreich DS. Liquid injectable silicone: techniques for soft tissue augmentation. Clin Plast Surg 2000;27:595-612.
5. Rees TD, Ashley FL, Delgado JP. Silicone fluid injections for facial atrophy: a ten-year study. Plast Reconstr Surg 1973;52:118-27.
6. Limited Applications for Silicone Injections Using Dow Corning MDX4-4011. IDE Number L002702, final report to the FDA. Midland, MI: Dow Corning; 1990.
7. Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthet Plast Surg 1996;20:267-76.
8. Duffy DM. The silicone conundrum. a battle of anecdotes. Dermatol Surg 2002;28:590-4.
9. Orentreich D, Leone AS. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatol Surg 2004;30:548-51.
10. James J, Carruthers A, Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 2002;28:979-86.
11. Baselga E, Pujol R. Indurated plaques and persistent ulcers in an HIV-1 seropositive man. Silicone granulomas (reaction to silicone injection). Arch Dermatol 1994;130:788-9.
12. Murray CA, DeKoven J, Spaner DE. Foreign body granuloma: a new manifestation of immune restoration syndrome. J Cutan Med Surg 2003;7:38-42.
13. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader 2000;10:546-51.